Search Results - "Hummers, L."

A case-control study of the pathology of oesophageal disease in systematic sclerosis (scleroderma).

Authors: Roberts, C. G. P. Hummers, L. K. Ravich, W. J. et al.

Source: Gut (0017-5749). Dec2006, Vol. 55 Issue 12, p1697-1703. 7p. 4 Color Photographs, 2 Charts, 1 Graph.

Abnormal exhaled ethane concentrations in scleroderma.

Authors: Cope, K. A. Solga, S. F. Hummers, L. K. et al.

Source: Biomarkers. Jan/Feb2006, Vol. 11 Issue 1, p70-84. 15p. 4 Charts, 3 Graphs.

ECHOCARDIOGRAPHIC SCREENING FOR MILDLY ELEVATED PULMONARY ARTERY PRESSURE IN PATIENTS WITH SYSTEMIC SCLEROSIS: OBSERVATIONS FROM THE SEPVADIS TRIAL.

Authors: Lammi, M. R. Hassoun, P. M. Mathai, S. C. et al.

Source: Advances in Pulmonary Hypertension. 2025, Vol. 24 Issue 1, p46-47. 2p.

Biomarkers of vascular disease in scleroderma.

Authors: Hummers, L. K.¹

Source: Rheumatology. 2008, Vol. 47 Issue suppl_5, pv21-v22. 1p.

Caractéristiques cliniques et différences ethniques chez les patients atteints de sclérodermie systémique positifs aux anticorps anti-fibrillarine : une étude de cohorte multicentrique internationale.

Authors: D'Alessandro, R. Rodolfi, S. Shah, A.A. et al.

Source: Revue du Rhumatisme. 2025 Supplement 1, Vol. 92, pA198-A199. 2p.

PM-Scl and Th/To in systemic sclerosis: a comparison of different autoantibody assays.

Authors: Mecoli, C. A. Gutierrez-Alamillo, L. Yang, Q. et al.

Source: Clinical Rheumatology. Jul2021, Vol. 40 Issue 7, p2763-2769. 7p.

Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera.

Authors: Loizos N Lariccia L Weiner J et al.

Source: Arthritis & Rheumatism. Apr2009, Vol. 60 Issue 4, p1145-1151. 7p.

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension.

Authors: Fisher MR Mathai SC Champion HC et al.

Source: Arthritis & Rheumatism. Sep2006, Vol. 54 Issue 9, p3043-3050. 8p.

PRS3 Joint Modelling of Forced Vital Capacity Decline and Time to Hospitalization Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors: Stock, C. Kreuter, M. Del Galdo, F. et al.

Source: Value in Health. 2021 Supplement 1, Vol. 24, pS213-S213. 1p.

98: Determinants of survival in pulmonary hypertension associated with scleroderma

Authors: Girgis, R.E. Mathai, S.C. Champion, H.C. et al.

Source: Journal of Heart & Lung Transplantation. Feb2006 Supplement, Vol. 25, p77-78. 2p.

Differential Item Functioning on the Cochin Hand Function Scale Among People With Systemic Sclerosis by Language, Sex, and Disease Subtype: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort Study.

Authors: Xu M Harel D Carrier ME et al.

Corporate Authors: Xu M Harel D Carrier ME et al.

Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2025 Mar; Vol. 77 (3), pp. 393-401. Date of Electronic Publication: 2023 Nov 20.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2151-4658 (Electronic) Linking ISSN: 2151464X NLM ISO Abbreviation: Arthritis Care Res (Hoboken) Subsets: MEDLINE

Comparative Efficacy of Immunosuppressive Therapies in the Treatment of Diffuse Cutaneous Systemic Sclerosis.

Authors: White B Furst DE Frech TM et al.

Corporate Authors: White B Furst DE Frech TM et al.

Source: ACR open rheumatology [ACR Open Rheumatol] 2025 Mar; Vol. 7 (3), pp. e70004.

Publication Type: Journal Article

Journal Info: Publisher: John Wiley & Sons Inc Country of Publication: United States NLM ID: 101740025 Publication Model: Print Cited Medium: Internet ISSN: 2578-5745 (Electronic) Linking ISSN: 25785745 NLM ISO Abbreviation: ACR Open Rheumatol Subsets: PubMed not MEDLINE

Comparing Raynaud's phenomenon attack measurement tools: paper or smartphone application?

Authors: Wallwork RS Hu H Shah AA et al.

Source: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2025 Oct; Vol. 74, pp. 152765. Date of Electronic Publication: 2025 Jun 06.

Publication Type: Journal Article; Multicenter Study; Comparative Study; Randomized Controlled Trial

Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 1306053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-866X (Electronic) Linking ISSN: 00490172 NLM ISO Abbreviation: Semin Arthritis Rheum Subsets: MEDLINE

Sildenafil Versus Placebo for Early Pulmonary Vascular Disease in Scleroderma (SEPVADIS): protocol for a randomized controlled trial.

Authors: Lammi MR Mukherjee M Saketkoo LA et al.

Source: BMC pulmonary medicine [BMC Pulm Med] 2024 Apr 30; Vol. 24 (1), pp. 211. Date of Electronic Publication: 2024 Apr 30.

Publication Type: Clinical Trial Protocol; Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.

Authors: Spiera R Kuwana M Khanna D et al.

Corporate Authors: Spiera R Kuwana M Khanna D et al.

Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 Sep; Vol. 75 (9), pp. 1608-1618. Date of Electronic Publication: 2023 Jun 15.

Publication Type: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE

Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis.

Authors: Zheng B Wang M McKenna K et al.

Corporate Authors: Zheng B Wang M McKenna K et al.

Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2022 Nov; Vol. 74 (11), pp. 1806-1812. Date of Electronic Publication: 2022 Jul 12.

Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2151-4658 (Electronic) Linking ISSN: 2151464X NLM ISO Abbreviation: Arthritis Care Res (Hoboken) Subsets: MEDLINE

Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis.

Authors: Spiera R Hummers L Chung L et al.

Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2020 Aug; Vol. 72 (8), pp. 1350-1360. Date of Electronic Publication: 2020 Jul 17.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE

A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.

Authors: Saketkoo LA Frech T Varjú C et al.

Source: Best practice & research. Clinical rheumatology [Best Pract Res Clin Rheumatol] 2021 Sep; Vol. 35 (3), pp. 101707. Date of Electronic Publication: 2021 Sep 15.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101121149 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1770 (Electronic) Linking ISSN: 15216942 NLM ISO Abbreviation: Best Pract Res Clin Rheumatol Subsets: MEDLINE

A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale.

Authors: Spiera R Khanna D Kuwana M et al.

Source: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2021 Jul-Aug; Vol. 39 Suppl 131 (4), pp. 124-133. Date of Electronic Publication: 2021 Jul 21.

Publication Type: Journal Article; Clinical Trial Protocol

Journal Info: Publisher: Clinical And Experimental Rheumatology S.A.S Country of Publication: Italy NLM ID: 8308521 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0392-856X (Print) Linking ISSN: 0392856X NLM ISO Abbreviation: Clin Exp Rheumatol Subsets: MEDLINE

Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?

Authors: Frech TM VanBuren JM Startup E et al.

Source: Clinical rheumatology [Clin Rheumatol] 2021 Mar; Vol. 40 (3), pp. 965-971. Date of Electronic Publication: 2020 Oct 23.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949 (Electronic) Linking ISSN: 07703198 NLM ISO Abbreviation: Clin Rheumatol Subsets: MEDLINE